期刊
JOURNAL OF IMMUNOLOGY
卷 199, 期 5, 页码 1827-1834出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1700739
关键词
-
类别
资金
- National Institutes of Health [K08 AR06379, K08 HL105537]
- Duke Physician-Scientist Strong Start Award
- Dermatology Foundation Research grant
- National Natural Science Foundation [81201243]
- China Postdoctoral Science Foundation [2014M562671]
The innate immune components that modulate allergic contact hypersensitivity (CHS) responses are poorly defined. Using human skin from contact dermatitis patients and a mouse model of CHS, we find that hapten allergens disrupt the Arginase1 (Arg1) and inducible NO synthase (iNOS) dynamic in monocytes/macrophages (mono/M Phi), which renders those cells ineffectual in suppressing skin inflammation. Mice lacking Arg1 in M Phi develop increased CHS characterized by elevated ear thickening, mono/M Phi 2 dominated dermal inflammation, and increased iNOS and IL-6 expression compared with control mice. Treatment of Arg1(flox/flox); LysMCre(+/-) mice with a selective NOS inhibitor or knockout of Nos2, encoding iNOS, significantly ameliorates CHS. Our findings suggest a critical role for Arg1 in mono/M Phi in suppressing CHS through dampening Nos2 expression. These results support that increasing Arg1 may be a potential therapeutic avenue in treating allergic contact dermatitis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据